Literature DB >> 24381666

Does transperitoneal minimally invasive radical prostatectomy increase the amount of small bowel receiving salvage radiation?

Murilo A Luz1, Alan Dal Pra2, Hin-Yu Vincent Tu1, Marie Duclos2, Fabio L B Cury2, Bassel G Bachir1, Armen G Aprikian1, Simon Tanguay1, Wassim Kassouf1.   

Abstract

INTRODUCTION: Transperitoneal minimally invasive radical prostatectomy (MIRP) has become first choice for several urologists and patients dealing with localized prostate cancer. We evaluate the effect of postoperative radiation on the small bowel in patients who underwent extraperitoneal open versus transperitoneal MIRP.
METHODS: We reviewed all patients who received postoperative radiation from 2006 to 2010. Planning target volume (PTV) and surrounding organs, including the small bowel, were delineated. The presence of the small bowel in PTV and its volume in receiving each dose level were analyzed.
RESULTS: A total of 122 patients were included: 26 underwent MIRP and 96 underwent open prostatectomy. The median age of patients was 66 years, with median body mass index 27 kg/m(2). The total PTV dose was 66 Gy, with the minimum and maximum doses received by the small bowel 0.4 and 66.4 Gy, respectively. The maximum volume of small bowel that received the safe limit of 40 Gy was 569 cm(3). Of the 26 patients who underwent MIRP, 12 (46%) had small bowel identified inside the PTV compared to 57 (59%) among patients who underwent open prostatectomy (p = 0.228). The mean volume of the small bowel receiving 40 Gy was 26 and 67 cm(3) in open and MIRP groups, respectively (p = 0.006); the incidence of acute complications was the same in both groups.
CONCLUSIONS: Higher volumes of the small bowel are subjected to significant radiation after MIRP procedures compared to open procedures; however, we could not demonstrate any impact on acute complications. Whether there is a difference in late complications remains to be evaluated.

Entities:  

Year:  2013        PMID: 24381666      PMCID: PMC3876447          DOI: 10.5489/cuaj.265

Source DB:  PubMed          Journal:  Can Urol Assoc J        ISSN: 1911-6470            Impact factor:   1.862


  19 in total

1.  Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: preliminary safety results from the CHHiP randomised controlled trial.

Authors:  David Dearnaley; Isabel Syndikus; Georges Sumo; Margaret Bidmead; David Bloomfield; Catharine Clark; Annie Gao; Shama Hassan; Alan Horwich; Robert Huddart; Vincent Khoo; Peter Kirkbride; Helen Mayles; Philip Mayles; Olivia Naismith; Chris Parker; Helen Patterson; Martin Russell; Christopher Scrase; Chris South; John Staffurth; Emma Hall
Journal:  Lancet Oncol       Date:  2011-12-12       Impact factor: 41.316

2.  Acute radiation enteritis causing small bowel obstruction.

Authors:  N J Curtis; T Bryant; S Raj; A R Bateman; A H Mirnezami
Journal:  Ann R Coll Surg Engl       Date:  2011-10       Impact factor: 1.891

3.  Acute small bowel toxicity and preoperative chemoradiotherapy for rectal cancer: investigating dose-volume relationships and role for inverse planning.

Authors:  Lye Mun Tho; Martin Glegg; Jennifer Paterson; Christina Yap; Alice MacLeod; Marie McCabe; Alexander C McDonald
Journal:  Int J Radiat Oncol Biol Phys       Date:  2006-07-31       Impact factor: 7.038

4.  Laparoscopic insertion of pelvic tissue expander to prevent radiation enteritis prior to radiotherapy for prostate cancer.

Authors:  Gary D McKay; Karen Wong; Daniel R Kozman
Journal:  Radiat Oncol       Date:  2011-05-14       Impact factor: 3.481

5.  Radical surgery for prostatic cancer.

Authors:  P C Walsh; H J Jewett
Journal:  Cancer       Date:  1980-04-15       Impact factor: 6.860

6.  Patient positioning variations to reduce dose to normal tissues during 3D conformal radiotherapy for high-risk prostate cancer.

Authors:  K Czigner; P Agoston; G Forgács; M Kásler
Journal:  Strahlenther Onkol       Date:  2012-05-23       Impact factor: 3.621

7.  Laparoscopic radical prostatectomy: technical and early oncological assessment of 40 operations.

Authors:  B Guillonneau; X Cathelineau; E Barret; F Rozet; G Vallancien
Journal:  Eur Urol       Date:  1999       Impact factor: 20.096

8.  Cancer statistics, 2010.

Authors:  Ahmedin Jemal; Rebecca Siegel; Jiaquan Xu; Elizabeth Ward
Journal:  CA Cancer J Clin       Date:  2010-07-07       Impact factor: 508.702

Review 9.  Treatment options for localized prostate cancer.

Authors:  Ravinder Mohan; Paul F Schellhammer
Journal:  Am Fam Physician       Date:  2011-08-15       Impact factor: 3.292

10.  Toxicity analysis of postoperative image-guided intensity-modulated radiotherapy for prostate cancer.

Authors:  Sameer K Nath; Ajay P Sandhu; Brent S Rose; Daniel R Simpson; Polly D Nobiensky; Jia-Zhu Wang; Fred Millard; Christopher J Kane; J Kellogg Parsons; Arno J Mundt
Journal:  Int J Radiat Oncol Biol Phys       Date:  2009-11-24       Impact factor: 7.038

View more
  1 in total

1.  Assessing the effects of radiation on the small bowel.

Authors:  Sanoj Punnen; Antonio Finelli
Journal:  Can Urol Assoc J       Date:  2013 Nov-Dec       Impact factor: 1.862

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.